INARI MED INC's ticker is NARI and the CUSIP is 45332Y109. A total of 256 filers reported holding INARI MED INC in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,939,613 | +5.9% | 656,569 | -5.9% | 0.01% | 0.0% |
| Q2 2023 | $40,561,313 | +4.2% | 697,649 | +10.6% | 0.01% | 0.0% |
| Q1 2023 | $38,932,998 | -9.8% | 630,596 | -7.1% | 0.01% | -11.1% |
| Q4 2022 | $43,160,227 | -12.4% | 679,047 | +0.2% | 0.01% | -18.2% |
| Q3 2022 | $49,252,000 | +16.7% | 678,028 | +9.2% | 0.01% | +22.2% |
| Q2 2022 | $42,212,000 | +20.5% | 620,845 | +60.7% | 0.01% | +50.0% |
| Q1 2022 | $35,026,000 | +12.1% | 386,430 | +12.9% | 0.01% | +20.0% |
| Q4 2021 | $31,247,000 | +13.1% | 342,364 | +0.5% | 0.01% | 0.0% |
| Q3 2021 | $27,629,000 | -1.3% | 340,668 | +13.6% | 0.01% | 0.0% |
| Q2 2021 | $27,981,000 | +52.1% | 299,975 | +74.5% | 0.01% | +66.7% |
| Q1 2021 | $18,398,000 | +107.8% | 171,937 | +69.5% | 0.00% | +50.0% |
| Q4 2020 | $8,853,000 | +25.7% | 101,413 | -0.6% | 0.00% | 0.0% |
| Q3 2020 | $7,044,000 | +730.7% | 102,052 | +483.3% | 0.00% | – |
| Q2 2020 | $848,000 | – | 17,497 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darsana Capital Partners LP | 1,475,000 | $137,588,000 | 3.91% |
| Affinity Asset Advisors, LLC | 85,000 | $7,929,000 | 2.84% |
| Parian Global Management LP | 49,800 | $4,645,000 | 1.99% |
| AlpInvest Partners B.V. | 27,960 | $2,608,000 | 1.28% |
| Sio Capital Management, LLC | 46,332 | $4,322,000 | 1.07% |
| HARBOURVEST PARTNERS LLC | 88,598 | $8,264,000 | 0.79% |
| HAMILTON LANE ADVISORS LLC | 26,403 | $2,463,000 | 0.77% |
| Pier Capital, LLC | 76,708 | $7,155,000 | 0.72% |
| Lisanti Capital Growth, LLC | 46,035 | $4,294,000 | 0.53% |
| NEXT CENTURY GROWTH INVESTORS LLC | 66,822 | $6,233,000 | 0.49% |